Future of Metabolic Endoscopy

Abstract Obesity has been escalating as one of the worst public health epidemics. Conservative therapies including lifestyle modifications and weight loss medications have limited efficacy and long-term sustainability. Bariatric surgeries, although effective, remain underutilized due to their cost,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of digestive endoscopy 2022-09, Vol.13 (3), p.170-178
Main Authors: Ghazi, Rabih, Vargas, Eric J., Abboud, Donna, Abdul Razak, Farah, Mahmoud, Tala, Storm, Andrew C., Chandrasekhara, Vinay, Abu Dayyeh, Barham K.
Format: Article
Language:English
Subjects:
endoscopic bariatric and metabolic therapies (ebmt)
endoscopic obesity
endoscopic sleeve gastroplasty (esg)
intragastric balloons (igb)
metabolic endoscopy
primary obesity surgery endoluminal (pose)
Review Article
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Obesity has been escalating as one of the worst public health epidemics. Conservative therapies including lifestyle modifications and weight loss medications have limited efficacy and long-term sustainability. Bariatric surgeries, although effective, remain underutilized due to their cost, safety concerns, and patient acceptance. In the past two decades, endoscopic bariatric and metabolic therapies (EBMTs) have emerged as safe, effective, and less invasive options for the treatment of obesity and its comorbidities, with recent studies reporting favorable outcomes in terms of weight loss and metabolic parameters. This article reviews the major and newly developed EBMTs, with emphasis on their metabolic effects and potential use in the management of metabolic conditions.
ISSN:0976-5042
0976-5050
DOI:10.1055/s-0042-1754335